Leverkusen, Germany | Reuters — German drugs and pesticides maker Bayer forecast a year without earnings growth for its agricultural products business on Wednesday, as it seeks to complete its US$66 billion deal to take over U.S. seeds giant Monsanto. Bayer has said the deal, which would put the size of its agricultural business on
Bayer sees pesticide profits stagnating before Monsanto takeover
Syngenta sees ChemChina deal closing in second quarter
Reuters — Swiss pesticides and seeds group Syngenta pushed back the expected closure of its agreed US$43 billion takeover by ChemChina to the second quarter of 2017, but said it was making progress in winning regulatory approval for the deal. The transaction is important for China, the world’s largest agricultural market, which is looking to
Bayer betting billions farmers will back linked-up supplies
Frankfurt | Reuters — Bayer’s US$66 billion purchase of Monsanto amounts to a long-term bet that farmers will grow to trust combinations of seeds and pesticides rather than continue to pick from ranges of separate products. In the short term, the German drugs and chemicals firm hopes to benefit from a marketing and sales force
Bayer clinches Monsanto with raised US$66 billion bid
New York/Frankfurt | Reuters — German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of US$66 billion including debt, ending months of wrangling after increasing its bid for a third time. The $128 a share deal announced on Wednesday, up from Bayer’s previous offer of
Bayer sweetens Monsanto bid as talks enter final stretch
Reuters — German pharmaceutical and crops manufacturer Bayer said on Monday that its negotiations with Monsanto had advanced, and that it was now willing to offer more than US$65 billion to acquire the world’s largest seeds company. Bayer’s announcement came as the gap in price expectations between the two companies has narrowed significantly, although important
Monsanto says no to $64-billion question
Monsanto says Bayer's latest bid financially inadequate, but open to talks
(Reuters) — U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG, but said it was open to further talks with the German healthcare and chemicals group as well as other parties. The widely expected rejection puts pressure on Bayer to sweeten its offer once again, at least enough
Bayer to consider shedding animal health unit
Leverkusen, Germany | Reuters –– Bayer might look into selling its animal health division if it continues to struggle to find takeover targets for the business, the German drugmaker’s incoming chief executive said. “Animal Health is a business that we have been trying for many years to strengthen strategically, that is to say inorganically. That
Bayer sizing up deals to strengthen seeds operation
Leverkusen, Germany | Reuters — Bayer’s Crop Science business is casting its eye over potential targets to enhance its seeds operation, the division’s head said on Thursday, as competitive threats increase with big mergers among its rivals. The Bayer CropScience operation comprises the world’s second-largest pesticides supplier but remains a much smaller player in seeds,
China seeks food security with friendly bid for Syngenta
Basel | Reuters — China made its boldest overseas takeover move when state-owned ChemChina agreed a US$43 billion bid for Swiss seeds and pesticides group Syngenta on Wednesday, aiming to improve domestic food production. The largest ever foreign purchase by a Chinese firm, announced by both companies, will accelerate a shake-up in global agrochemicals and
Syngenta ready to play role in sector shake-up
Frankfurt | Reuters — Syngenta and other major seeds and crop chemicals companies are intensively discussing tie-ups, the Financial Times quoted the Swiss firm’s chairman as saying Wednesday, adding to a chorus of voices predicting a sector shake-up. Conversations among the leading players in the industry are “extremely active,” the newspaper quoted Michel Demare as